ID   UB2D2_HUMAN             Reviewed;         147 AA.
AC   P62837; D3DQC9; P51669; Q3MN78; Q96RP6;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2004, sequence version 1.
DT   10-MAY-2017, entry version 153.
DE   RecName: Full=Ubiquitin-conjugating enzyme E2 D2;
DE            EC=2.3.2.23 {ECO:0000269|PubMed:18042044, ECO:0000269|PubMed:18703417, ECO:0000269|PubMed:19854139, ECO:0000269|PubMed:20061386};
DE   AltName: Full=(E3-independent) E2 ubiquitin-conjugating enzyme D2;
DE            EC=2.3.2.24 {ECO:0000269|PubMed:17588522};
DE   AltName: Full=E2 ubiquitin-conjugating enzyme D2;
DE   AltName: Full=Ubiquitin carrier protein D2;
DE   AltName: Full=Ubiquitin-conjugating enzyme E2(17)KB 2;
DE   AltName: Full=Ubiquitin-conjugating enzyme E2-17 kDa 2;
DE   AltName: Full=Ubiquitin-protein ligase D2;
DE   AltName: Full=p53-regulated ubiquitin-conjugating enzyme 1;
GN   Name=UBE2D2; Synonyms=PUBC1, UBC4, UBC5B, UBCH4, UBCH5B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Peripheral blood lymphocyte;
RX   PubMed=8530467; DOI=10.1074/jbc.270.51.30408;
RA   Jensen J.P., Bates P.W., Yang M., Vierstra R.D., Weissman A.M.;
RT   "Identification of a family of closely related human ubiquitin
RT   conjugating enzymes.";
RL   J. Biol. Chem. 270:30408-30414(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=7724550; DOI=10.1073/pnas.92.8.3264;
RA   Rolfe M., Beer-Romero P., Glass S., Eckstein J., Berdo I.,
RA   Theodoras A., Pagano M., Draetta G.;
RT   "Reconstitution of p53-ubiquitinylation reactions from purified
RT   components: the role of human ubiquitin-conjugating enzyme UBC4 and
RT   E6-associated protein (E6AP).";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:3264-3268(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=16112646; DOI=10.1016/j.bbrc.2005.08.024;
RA   Guinn B.-A., Bland E.A., Lodi U., Liggins A.P., Tobal K., Petters S.,
RA   Wells J.W., Banham A.H., Mufti G.J.;
RT   "Humoral detection of leukaemia-associated antigens in presentation
RT   acute myeloid leukaemia.";
RL   Biochem. Biophys. Res. Commun. 335:1293-1304(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Yin Y.;
RT   "Cloning and identification of a p53-regulated ubiquitin-conjugating
RT   enzyme, PUBC1.";
RL   Submitted (OCT-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 73-90, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [10]
RP   FUNCTION, AND MUTAGENESIS OF CYS-85.
RX   PubMed=10329681; DOI=10.1074/jbc.274.21.14823;
RA   Gonen H., Bercovich B., Orian A., Carrano A., Takizawa C.,
RA   Yamanaka K., Pagano M., Iwai K., Ciechanover A.;
RT   "Identification of the ubiquitin carrier proteins, E2s, involved in
RT   signal-induced conjugation and subsequent degradation of
RT   IkappaBalpha.";
RL   J. Biol. Chem. 274:14823-14830(1999).
RN   [11]
RP   INTERACTION WITH SCF COMPLEX.
RX   PubMed=10918611; DOI=10.1038/sj.onc.1203647;
RA   Strack P., Caligiuri M., Pelletier M., Boisclair M., Theodoras A.,
RA   Beer-Romero P., Glass S., Parsons T., Copeland R.A., Auger K.R.,
RA   Benfield P., Brizuela L., Rolfe M.;
RT   "SCF(beta-TRCP) and phosphorylation dependent ubiquitination of I
RT   kappa B alpha catalyzed by Ubc3 and Ubc4.";
RL   Oncogene 19:3529-3536(2000).
RN   [12]
RP   INTERACTION WITH PJA1 AND PJA2.
RX   PubMed=12036302; DOI=10.1006/geno.2002.6770;
RA   Yu P., Chen Y., Tagle D.A., Cai T.;
RT   "PJA1, encoding a RING-H2 finger ubiquitin ligase, is a novel human X
RT   chromosome gene abundantly expressed in brain.";
RL   Genomics 79:869-874(2002).
RN   [13]
RP   FUNCTION.
RX   PubMed=15280377; DOI=10.1074/jbc.M403362200;
RA   Saville M.K., Sparks A., Xirodimas D.P., Wardrop J., Stevenson L.F.,
RA   Bourdon J.C., Woods Y.L., Lane D.P.;
RT   "Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in
RT   vivo.";
RL   J. Biol. Chem. 279:42169-42181(2004).
RN   [14]
RP   INTERACTION WITH CNOT4, AND MUTAGENESIS OF LYS-63.
RX   PubMed=15001359; DOI=10.1016/j.jmb.2004.01.031;
RA   Winkler G.S., Albert T.K., Dominguez C., Legtenberg Y.I., Boelens R.,
RA   Timmers H.T.;
RT   "An altered-specificity ubiquitin-conjugating enzyme/ubiquitin-protein
RT   ligase pair.";
RL   J. Mol. Biol. 337:157-165(2004).
RN   [15]
RP   CATALYTIC ACTIVITY AS E3-INDEPENDENT E2 UBIQUITIN-CONJUGATING ENZYME.
RX   PubMed=17588522; DOI=10.1016/j.molcel.2007.05.014;
RA   Hoeller D., Hecker C.M., Wagner S., Rogov V., Doetsch V., Dikic I.;
RT   "E3-independent monoubiquitination of ubiquitin-binding proteins.";
RL   Mol. Cell 26:891-898(2007).
RN   [16]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=18042044; DOI=10.1042/BJ20071338;
RA   Windheim M., Peggie M., Cohen P.;
RT   "Two different classes of E2 ubiquitin-conjugating enzymes are
RT   required for the mono-ubiquitination of proteins and elongation by
RT   polyubiquitin chains with a specific topology.";
RL   Biochem. J. 409:723-729(2008).
RN   [17]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF CYS-85.
RX   PubMed=18703417; DOI=10.1095/biolreprod.108.071407;
RA   Chiang M.H., Chen L.F., Chen H.;
RT   "Ubiquitin-conjugating enzyme UBE2D2 is responsible for FBXW2 (F-box
RT   and WD repeat domain containing 2)-mediated human GCM1 (glial cell
RT   missing homolog 1) ubiquitination and degradation.";
RL   Biol. Reprod. 79:914-920(2008).
RN   [18]
RP   FUNCTION.
RX   PubMed=18359941; DOI=10.1074/jbc.M800402200;
RA   Grou C.P., Carvalho A.F., Pinto M.P., Wiese S., Piechura H.,
RA   Meyer H.E., Warscheid B., Sa-Miranda C., Azevedo J.E.;
RT   "Members of the E2D (UbcH5) family mediate the ubiquitination of the
RT   conserved cysteine of Pex5p, the peroxisomal import receptor.";
RL   J. Biol. Chem. 283:14190-14197(2008).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=19854139; DOI=10.1016/j.molcel.2009.09.037;
RA   Zeng W., Xu M., Liu S., Sun L., Chen Z.J.;
RT   "Key role of Ubc5 and lysine-63 polyubiquitination in viral activation
RT   of IRF3.";
RL   Mol. Cell 36:315-325(2009).
RN   [20]
RP   FUNCTION.
RX   PubMed=20403326; DOI=10.1016/j.cell.2010.03.029;
RA   Zeng W., Sun L., Jiang X., Chen X., Hou F., Adhikari A., Xu M.,
RA   Chen Z.J.;
RT   "Reconstitution of the RIG-I pathway reveals a signaling role of
RT   unanchored polyubiquitin chains in innate immunity.";
RL   Cell 141:315-330(2010).
RN   [21]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=20061386; DOI=10.1074/jbc.M109.089003;
RA   David Y., Ziv T., Admon A., Navon A.;
RT   "The E2 ubiquitin-conjugating enzymes direct polyubiquitination to
RT   preferred lysines.";
RL   J. Biol. Chem. 285:8595-8604(2010).
RN   [22]
RP   FUNCTION, INTERACTION WITH CBLC, AND MUTAGENESIS OF CYS-85.
RX   PubMed=20525694; DOI=10.1074/jbc.M109.091157;
RA   Ryan P.E., Sivadasan-Nair N., Nau M.M., Nicholas S., Lipkowitz S.;
RT   "The N terminus of Cbl-c regulates ubiquitin ligase activity by
RT   modulating affinity for the ubiquitin-conjugating enzyme.";
RL   J. Biol. Chem. 285:23687-23698(2010).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [24]
RP   STRUCTURE BY NMR.
RX   PubMed=15522302; DOI=10.1016/j.jmb.2004.09.054;
RA   Houben K., Dominguez C., van Schaik F.M., Timmers H.T., Bonvin A.M.,
RA   Boelens R.;
RT   "Solution structure of the ubiquitin-conjugating enzyme UbcH5B.";
RL   J. Mol. Biol. 344:513-526(2004).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS).
RX   PubMed=20152160; DOI=10.1016/j.str.2009.11.007;
RA   Sakata E., Satoh T., Yamamoto S., Yamaguchi Y., Yagi-Utsumi M.,
RA   Kurimoto E., Tanaka K., Wakatsuki S., Kato K.;
RT   "Crystal structure of UbcH5b~ubiquitin intermediate: insight into the
RT   formation of the self-assembled E2~Ub conjugates.";
RL   Structure 18:138-147(2010).
RN   [26] {ECO:0000244|PDB:5D0K, ECO:0000244|PDB:5D0M}
RP   X-RAY CRYSTALLOGRAPHY (1.91 ANGSTROMS) IN COMPLEX WITH RNF165.
RX   PubMed=26656854; DOI=10.1038/nsmb.3142;
RA   Wright J.D., Mace P.D., Day C.L.;
RT   "Secondary ubiquitin-RING docking enhances Arkadia and Ark2C E3 ligase
RT   activity.";
RL   Nat. Struct. Mol. Biol. 23:45-52(2016).
CC   -!- FUNCTION: Accepts ubiquitin from the E1 complex and catalyzes its
CC       covalent attachment to other proteins. In vitro catalyzes 'Lys-
CC       48'-linked polyubiquitination. Mediates the selective degradation
CC       of short-lived and abnormal proteins. Functions in the E6/E6-AP-
CC       induced ubiquitination of p53/TP53. Mediates ubiquitination of
CC       PEX5 and autoubiquitination of STUB1 and TRAF6. Involved in the
CC       signal-induced conjugation and subsequent degradation of NFKBIA,
CC       FBXW2-mediated GCM1 ubiquitination and degradation, MDM2-dependent
CC       degradation of p53/TP53 and the activation of MAVS in the
CC       mitochondria by DDX58/RIG-I in response to viral infection.
CC       Essential for viral activation of IRF3.
CC       {ECO:0000269|PubMed:10329681, ECO:0000269|PubMed:15280377,
CC       ECO:0000269|PubMed:18042044, ECO:0000269|PubMed:18359941,
CC       ECO:0000269|PubMed:18703417, ECO:0000269|PubMed:19854139,
CC       ECO:0000269|PubMed:20061386, ECO:0000269|PubMed:20403326,
CC       ECO:0000269|PubMed:20525694}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E1 ubiquitin-activating
CC       enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine
CC       = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2
CC       ubiquitin-conjugating enzyme]-L-cysteine. {ECO:0000255|PROSITE-
CC       ProRule:PRU00388, ECO:0000255|PROSITE-ProRule:PRU10133,
CC       ECO:0000269|PubMed:18042044, ECO:0000269|PubMed:18703417,
CC       ECO:0000269|PubMed:19854139, ECO:0000269|PubMed:20061386}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E1 ubiquitin-activating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E1 ubiquitin-
CC       activating enzyme]-L-cysteine + N(6)-monoubiquitinyl-[acceptor
CC       protein]-L-lysine. {ECO:0000269|PubMed:17588522}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000255|PROSITE-ProRule:PRU00388}.
CC   -!- SUBUNIT: Interacts with SCF (SKP1-CUL1-F-box protein) E3 ubiquitin
CC       ligase complex. Interacts with CNOT4 (via RING domain). Interacts
CC       with E3 ubiquitin-protein ligases CBLC, PJA1 and PJA2. Interacts
CC       with PDZRN3. {ECO:0000269|PubMed:10918611,
CC       ECO:0000269|PubMed:12036302, ECO:0000269|PubMed:15001359,
CC       ECO:0000269|PubMed:20525694}.
CC   -!- INTERACTION:
CC       O15151:MDM4; NbExp=2; IntAct=EBI-347677, EBI-398437;
CC       O15344:MID1; NbExp=3; IntAct=EBI-347677, EBI-2340316;
CC       Q99PZ6:ospG (xeno); NbExp=3; IntAct=EBI-347677, EBI-9316527;
CC       Q96FW1:OTUB1; NbExp=11; IntAct=EBI-347677, EBI-1058491;
CC       Q9Y3C5:RNF11; NbExp=7; IntAct=EBI-347677, EBI-396669;
CC       Q9Y4L5:RNF115; NbExp=5; IntAct=EBI-347677, EBI-2129242;
CC       Q9BV68:RNF126; NbExp=4; IntAct=EBI-347677, EBI-357322;
CC       Q96GF1:RNF185; NbExp=3; IntAct=EBI-347677, EBI-2340249;
CC       Q99496:RNF2; NbExp=3; IntAct=EBI-347677, EBI-722416;
CC       Q68DV7:RNF43; NbExp=2; IntAct=EBI-347677, EBI-1647060;
CC       Q99942:RNF5; NbExp=5; IntAct=EBI-347677, EBI-348482;
CC       Q9Y4K3:TRAF6; NbExp=4; IntAct=EBI-347677, EBI-359276;
CC       P98170:XIAP; NbExp=2; IntAct=EBI-347677, EBI-517127;
CC       Q8ND25:ZNRF1; NbExp=4; IntAct=EBI-347677, EBI-2129250;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P62837-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P62837-2; Sequence=VSP_045180;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the ubiquitin-conjugating enzyme family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00388}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U39317; AAA91460.1; -; mRNA.
DR   EMBL; L40146; AAC41750.1; -; Genomic_DNA.
DR   EMBL; AY651263; AAX35690.1; -; mRNA.
DR   EMBL; AF317220; AAK93958.1; -; mRNA.
DR   EMBL; AK001311; BAG50891.1; -; mRNA.
DR   EMBL; AK001428; BAG50911.1; -; mRNA.
DR   EMBL; AC010378; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471062; EAW62095.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW62096.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW62097.1; -; Genomic_DNA.
DR   EMBL; BC033349; AAH33349.1; -; mRNA.
DR   CCDS; CCDS43369.1; -. [P62837-1]
DR   CCDS; CCDS47275.1; -. [P62837-2]
DR   PIR; I59365; I59365.
DR   RefSeq; NP_003330.1; NM_003339.2. [P62837-1]
DR   RefSeq; NP_862821.1; NM_181838.1. [P62837-2]
DR   UniGene; Hs.108332; -.
DR   PDB; 1UR6; NMR; -; A=1-147.
DR   PDB; 1W4U; NMR; -; A=1-147.
DR   PDB; 2CLW; X-ray; 1.94 A; A/B/C/D=1-147.
DR   PDB; 2ESK; X-ray; 1.36 A; A=1-147.
DR   PDB; 2ESO; X-ray; 1.50 A; A=1-147.
DR   PDB; 2ESP; X-ray; 1.52 A; A=1-147.
DR   PDB; 2ESQ; X-ray; 1.44 A; A=1-147.
DR   PDB; 3A33; X-ray; 2.20 A; A=1-147.
DR   PDB; 3JVZ; X-ray; 3.30 A; A/B=2-147.
DR   PDB; 3JW0; X-ray; 3.10 A; A/B=2-147.
DR   PDB; 3L1Y; X-ray; 1.60 A; A=1-147.
DR   PDB; 3TGD; X-ray; 1.80 A; A=1-147.
DR   PDB; 3ZNI; X-ray; 2.21 A; C/G/K/O=2-147.
DR   PDB; 4A49; X-ray; 2.21 A; B=1-147.
DR   PDB; 4A4B; X-ray; 2.79 A; C=1-147.
DR   PDB; 4A4C; X-ray; 2.70 A; C=1-147.
DR   PDB; 4AUQ; X-ray; 2.18 A; A/D=1-147.
DR   PDB; 4DDG; X-ray; 3.30 A; A/B/C/J/K/L=1-147.
DR   PDB; 4LDT; X-ray; 1.90 A; C=1-147.
DR   PDB; 4V3K; X-ray; 2.04 A; A/D=2-147.
DR   PDB; 4V3L; X-ray; 1.53 A; A=2-147.
DR   PDB; 4WZ3; X-ray; 2.70 A; A=1-147.
DR   PDB; 5D0K; X-ray; 2.65 A; A/D/G/J=1-147.
DR   PDB; 5D0M; X-ray; 1.91 A; A=1-147.
DR   PDB; 5D1K; X-ray; 1.78 A; A=1-147.
DR   PDB; 5D1L; X-ray; 1.62 A; A=1-147.
DR   PDB; 5D1M; X-ray; 1.58 A; A=1-147.
DR   PDB; 5EDV; X-ray; 3.48 A; C/D/I=2-147.
DR   PDBsum; 1UR6; -.
DR   PDBsum; 1W4U; -.
DR   PDBsum; 2CLW; -.
DR   PDBsum; 2ESK; -.
DR   PDBsum; 2ESO; -.
DR   PDBsum; 2ESP; -.
DR   PDBsum; 2ESQ; -.
DR   PDBsum; 3A33; -.
DR   PDBsum; 3JVZ; -.
DR   PDBsum; 3JW0; -.
DR   PDBsum; 3L1Y; -.
DR   PDBsum; 3TGD; -.
DR   PDBsum; 3ZNI; -.
DR   PDBsum; 4A49; -.
DR   PDBsum; 4A4B; -.
DR   PDBsum; 4A4C; -.
DR   PDBsum; 4AUQ; -.
DR   PDBsum; 4DDG; -.
DR   PDBsum; 4LDT; -.
DR   PDBsum; 4V3K; -.
DR   PDBsum; 4V3L; -.
DR   PDBsum; 4WZ3; -.
DR   PDBsum; 5D0K; -.
DR   PDBsum; 5D0M; -.
DR   PDBsum; 5D1K; -.
DR   PDBsum; 5D1L; -.
DR   PDBsum; 5D1M; -.
DR   PDBsum; 5EDV; -.
DR   ProteinModelPortal; P62837; -.
DR   SMR; P62837; -.
DR   BioGrid; 113170; 238.
DR   DIP; DIP-29267N; -.
DR   IntAct; P62837; 110.
DR   MINT; MINT-1035011; -.
DR   STRING; 9606.ENSP00000381717; -.
DR   TCDB; 3.A.20.1.1; the peroxisomal protein importer (ppi) family.
DR   iPTMnet; P62837; -.
DR   PhosphoSitePlus; P62837; -.
DR   BioMuta; UBE2D2; -.
DR   DMDM; 51338685; -.
DR   EPD; P62837; -.
DR   MaxQB; P62837; -.
DR   PaxDb; P62837; -.
DR   PeptideAtlas; P62837; -.
DR   PRIDE; P62837; -.
DR   Ensembl; ENST00000398733; ENSP00000381717; ENSG00000131508. [P62837-1]
DR   Ensembl; ENST00000398734; ENSP00000381718; ENSG00000131508. [P62837-1]
DR   Ensembl; ENST00000505548; ENSP00000424941; ENSG00000131508. [P62837-2]
DR   Ensembl; ENST00000511725; ENSP00000429613; ENSG00000131508. [P62837-2]
DR   GeneID; 7322; -.
DR   KEGG; hsa:7322; -.
DR   UCSC; uc003ler.3; human. [P62837-1]
DR   CTD; 7322; -.
DR   DisGeNET; 7322; -.
DR   GeneCards; UBE2D2; -.
DR   H-InvDB; HIX0019025; -.
DR   H-InvDB; HIX0028451; -.
DR   HGNC; HGNC:12475; UBE2D2.
DR   HPA; HPA003920; -.
DR   MIM; 602962; gene.
DR   neXtProt; NX_P62837; -.
DR   OpenTargets; ENSG00000131508; -.
DR   PharmGKB; PA37125; -.
DR   eggNOG; KOG0417; Eukaryota.
DR   eggNOG; COG5078; LUCA.
DR   GeneTree; ENSGT00760000119012; -.
DR   HOGENOM; HOG000233455; -.
DR   HOVERGEN; HBG063308; -.
DR   InParanoid; P62837; -.
DR   KO; K06689; -.
DR   OMA; YAGGVYF; -.
DR   PhylomeDB; P62837; -.
DR   TreeFam; TF101108; -.
DR   BioCyc; MetaCyc:HS05542-MONOMER; -.
DR   BRENDA; 2.3.2.B5; 2681.
DR   BRENDA; 2.3.2.B6; 2681.
DR   BRENDA; 2.3.2.B8; 2681.
DR   Reactome; R-HSA-1234176; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha.
DR   Reactome; R-HSA-202424; Downstream TCR signaling.
DR   Reactome; R-HSA-2871837; FCERI mediated NF-kB activation.
DR   Reactome; R-HSA-5607764; CLEC7A (Dectin-1) signaling.
DR   Reactome; R-HSA-8866652; Synthesis of active ubiquitin: roles of E1 and E2 enzymes.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   Reactome; R-HSA-936440; Negative regulators of RIG-I/MDA5 signaling.
DR   Reactome; R-HSA-937041; IKK complex recruitment mediated by RIP1.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; P62837; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; UBE2D2; human.
DR   EvolutionaryTrace; P62837; -.
DR   GeneWiki; UBE2D2; -.
DR   GenomeRNAi; 7322; -.
DR   PRO; PR:P62837; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000131508; -.
DR   CleanEx; HS_UBE2D2; -.
DR   ExpressionAtlas; P62837; baseline and differential.
DR   Genevisible; P62837; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0043234; C:protein complex; IDA:MGI.
DR   GO; GO:0000151; C:ubiquitin ligase complex; IDA:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0061631; F:ubiquitin conjugating enzyme activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0006464; P:cellular protein modification process; TAS:ProtInc.
DR   GO; GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0051865; P:protein autoubiquitination; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; IDA:BHF-UCL.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome.
DR   GO; GO:0002223; P:stimulatory C-type lectin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc.
DR   CDD; cd00195; UBCc; 1.
DR   Gene3D; 3.10.110.10; -; 1.
DR   InterPro; IPR000608; UBQ-conjugat_E2.
DR   InterPro; IPR023313; UBQ-conjugating_AS.
DR   InterPro; IPR016135; UBQ-conjugating_enzyme/RWD.
DR   Pfam; PF00179; UQ_con; 1.
DR   SUPFAM; SSF54495; SSF54495; 1.
DR   PROSITE; PS00183; UBIQUITIN_CONJUGAT_1; 1.
DR   PROSITE; PS50127; UBIQUITIN_CONJUGAT_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Direct protein sequencing; Nucleotide-binding; Reference proteome;
KW   Transferase; Ubl conjugation pathway.
FT   CHAIN         1    147       Ubiquitin-conjugating enzyme E2 D2.
FT                                /FTId=PRO_0000082462.
FT   ACT_SITE     85     85       Glycyl thioester intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00388,
FT                                ECO:0000255|PROSITE-ProRule:PRU10133}.
FT   VAR_SEQ       1     29       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_045180.
FT   MUTAGEN      63     63       K->A,E: Strongly reduced interaction with
FT                                CNTO4. {ECO:0000269|PubMed:15001359}.
FT   MUTAGEN      85     85       C->A: Catalytically inactive. Loss of
FT                                ability to promote FBXW2-mediated GCM1
FT                                ubiquitination. Inhibition of TNF-alpha-
FT                                induced degradation of NFKBIA.
FT                                {ECO:0000269|PubMed:10329681,
FT                                ECO:0000269|PubMed:18703417,
FT                                ECO:0000269|PubMed:20525694}.
FT   CONFLICT    128    128       K -> Q (in Ref. 2; AAC41750).
FT                                {ECO:0000305}.
FT   HELIX         1     15       {ECO:0000244|PDB:2ESK}.
FT   STRAND       19     28       {ECO:0000244|PDB:2ESK}.
FT   STRAND       32     38       {ECO:0000244|PDB:2ESK}.
FT   STRAND       41     43       {ECO:0000244|PDB:4V3L}.
FT   TURN         44     47       {ECO:0000244|PDB:2ESK}.
FT   STRAND       49     55       {ECO:0000244|PDB:2ESK}.
FT   TURN         58     61       {ECO:0000244|PDB:2ESK}.
FT   STRAND       66     71       {ECO:0000244|PDB:2ESK}.
FT   STRAND       76     78       {ECO:0000244|PDB:4A4B}.
FT   STRAND       82     84       {ECO:0000244|PDB:1W4U}.
FT   HELIX        87     89       {ECO:0000244|PDB:2ESK}.
FT   TURN         90     92       {ECO:0000244|PDB:2ESK}.
FT   HELIX        99    111       {ECO:0000244|PDB:2ESK}.
FT   STRAND      115    117       {ECO:0000244|PDB:4V3L}.
FT   HELIX       121    129       {ECO:0000244|PDB:2ESK}.
FT   HELIX       131    145       {ECO:0000244|PDB:2ESK}.
SQ   SEQUENCE   147 AA;  16735 MW;  C942BE7853CBC355 CRC64;
     MALKRIHKEL NDLARDPPAQ CSAGPVGDDM FHWQATIMGP NDSPYQGGVF FLTIHFPTDY
     PFKPPKVAFT TRIYHPNINS NGSICLDILR SQWSPALTIS KVLLSICSLL CDPNPDDPLV
     PEIARIYKTD REKYNRIARE WTQKYAM
//
